Meeting
2021 Genitourinary Cancers Symposium
Genomic analysis for active surveillance to predict upstaging after prostatectomy.
Presenter
Andrea Quinn, BA
Sidney Kimmel Medical College at Thomas Jefferson University
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Videos & Slides Details
Session Type
Poster Session
Session Title
Poster Session: Prostate Cancer - Localized Disease
Track
Prostate Cancer - Localized
Sub Track
Tumor Biology, Biomarkers, and Pathology
Citation
J Clin Oncol 39, 2021 (suppl 6; abstr 258)
DOI
10.1200/JCO.2021.39.6_suppl.258
Abstract #
258
Poster Bd #
Online Only
Abstract Disclosures
Similar Videos & Slides
Videos & Slides
2023 ASCO Annual Meeting
How Do We Use Digital Health to Implement PROs in Cancer Care?
Speaker: Claire Frances Snyder, PhD
Videos & Slides
2023 ASCO Genitourinary Cancers Symposium
Predictor of adverse pathology in patients who underwent deferred radical prostatectomy following active surveillance: Results from multi-institutional prospective observational cohort in the PRIAS-JAPAN.
Speaker: Yoichiro Tohi, MD
Videos & Slides
2022 ASCO Genitourinary Cancers Symposium
Pathological and oncological outcomes of off-criteria radical prostatectomy in patients opting for active surveillance: From PRIAS-JAPAN.
Speaker: Yoichiro Tohi, MD
Videos & Slides
2021 ASCO Annual Meeting
Validation of the decipher genomic classifier (GC) in SAKK 09/10: A phase III randomized trial of dose-escalated salvage radiotherapy (SRT) after radical prostatectomy (RP).
Speaker: Alan Dal Pra, MD